HOTH News and Press, Hoth Therapeutics Inc. From 09/24/20

Hoth Therapeutics Announces its HT-003 Shows Positive Initial Data Inhibiting Toll-like Receptor 2 (TLR2) Initial data reports one of the most critical genes for acne pathophysiology, toll-like receptor 2 (TLR2), is significantly inhibited by HT-003 PR Newswire NEW YORK,...

Presentation Times and Weblinks Released for Over 150 Presenting Companies Day 1: Wednesday, September 23, 2020 ALL INSTITUTIONAL AND RETAIL INVESTORS ARE WELCOME NEW YORK, NY / ACCESSWIRE / September 22, 2020 / Sidoti & Company, LLC has released the presentation schedule,...

Hoth Therapeutics ([[HOTH]] -3.8%) has entered into a research agreement with the George Washington University, related to the development of an in vitro diagnostic device that allows immediate detection of SARS-CoV-2 via a mobile device.Nanohole array-based device utilizes plasmoni...

Hoth Therapeutics Enters into Sponsored Research Agreement for On-the-Go COVID-19 Testing Device Company will Partner with the George Washington University on R&D for their Licensed Smartphone-Based Direct Virus Sensing System PR Newswire NEW YORK, Sept. 21, 2020 ...

NEW YORK, Sept. 16, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. today announced that it has executed a manufacturing agreement for its vaccine portfolio with a global pharmaceutical contract development and manufacturing organization. The agreement partners Voltron with a multi-nati...

NEW YORK, Sept. 15, 2020 (GLOBE NEWSWIRE) -- Voltron Therapeutics, Inc. announced today the successful completion of its previously announced first small animal safety and immunogenicity study assessing the effect of novel Covid-19 vaccine HaloVax™. The vaccine construct was ad...

NEW YORK , Sept. 1 , 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH), a biopharmaceutical company, today announced  Dr. Stefanie Johns , who has agreed to join Hoth and serve as its Chief Scientific Officer, is scheduled to appear as a featured guest on On...

LOS ANGELES, CA / ACCESSWIRE / August 31, 2020 / LD Micro today announced the final list of companies slated to present at the upcoming LD 500, taking place September 1st-4th, 2020, exclusively online. Registration details and the company schedule can be seen here: https://ld500.ldmicro.co...

Hoth Therapeutics (NASDAQ: HOTH )  appoints of Stefanie Johns, Ph.D., to the position of Chief Scientific Officer, effective September 2020. More news on: Hoth Therapeutics, Inc., Healthcare stocks news, Read more ...

NEW YORK , Aug. 31, 2020 /PRNewswire/ -- Hoth Therapeutics, Inc. (NASDAQ: HOTH) a biopharmaceutical company, today announces the appointment of Stefanie Johns, Ph.D., to the position of Chief Scientific Officer, effective September 2020 . In her role, Dr. Johns will f...